Advanced search options

Advanced Search Options 🞨

Browse by author name (“Author name starts with…”).

Find ETDs with:

in
/  
in
/  
in
/  
in

Written in Published in Earliest date Latest date

Sorted by

Results per page:

Sorted by: relevance · author · university · dateNew search

You searched for subject:(Immune checkpoint). Showing records 1 – 30 of 47 total matches.

[1] [2]

Search Limiters

Last 2 Years | English Only

Country

▼ Search Limiters

1. Wu, Ching-Lien. Study of the immune checkpoint HLA-G/ILT2 : soluble receptors, inhibition of iNKT cells : Etude du checkpoint inhibiteur HLA-G/ILT2 : récepteurs solubles, inhibition des cellules iNKT.

Degree: Docteur es, Médecine. Biothérapies, 2018, Sorbonne Paris Cité

HLA-G est une molécule checkpoint immunologique tolérogène connue pour son rôle dans la tolerance materno-foetale, puis comme mécanisme d’échappement immunitaire des tumeurs. HLA-G exerce ses… (more)

Subjects/Keywords: ILT2; ILT4; Checkpoint inhibiteur; ILT2; ILT4; Immune checkpoint

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Wu, C. (2018). Study of the immune checkpoint HLA-G/ILT2 : soluble receptors, inhibition of iNKT cells : Etude du checkpoint inhibiteur HLA-G/ILT2 : récepteurs solubles, inhibition des cellules iNKT. (Doctoral Dissertation). Sorbonne Paris Cité. Retrieved from http://www.theses.fr/2018USPCC188

Chicago Manual of Style (16th Edition):

Wu, Ching-Lien. “Study of the immune checkpoint HLA-G/ILT2 : soluble receptors, inhibition of iNKT cells : Etude du checkpoint inhibiteur HLA-G/ILT2 : récepteurs solubles, inhibition des cellules iNKT.” 2018. Doctoral Dissertation, Sorbonne Paris Cité. Accessed January 16, 2021. http://www.theses.fr/2018USPCC188.

MLA Handbook (7th Edition):

Wu, Ching-Lien. “Study of the immune checkpoint HLA-G/ILT2 : soluble receptors, inhibition of iNKT cells : Etude du checkpoint inhibiteur HLA-G/ILT2 : récepteurs solubles, inhibition des cellules iNKT.” 2018. Web. 16 Jan 2021.

Vancouver:

Wu C. Study of the immune checkpoint HLA-G/ILT2 : soluble receptors, inhibition of iNKT cells : Etude du checkpoint inhibiteur HLA-G/ILT2 : récepteurs solubles, inhibition des cellules iNKT. [Internet] [Doctoral dissertation]. Sorbonne Paris Cité; 2018. [cited 2021 Jan 16]. Available from: http://www.theses.fr/2018USPCC188.

Council of Science Editors:

Wu C. Study of the immune checkpoint HLA-G/ILT2 : soluble receptors, inhibition of iNKT cells : Etude du checkpoint inhibiteur HLA-G/ILT2 : récepteurs solubles, inhibition des cellules iNKT. [Doctoral Dissertation]. Sorbonne Paris Cité; 2018. Available from: http://www.theses.fr/2018USPCC188

2. Santry, Lisa. Production of Preclinical Grade Recombinant Newcastle disease viruses to Enhance Tumor Specific Immune Responses in Syngeneic Mouse Models of Cancer.

Degree: PhD, Department of Pathobiology, 2018, University of Guelph

 Oncolytic virus (OV) therapy is an experimental form of biological therapy has shown increasing potential over the last decade, culminating with the first FDA approval… (more)

Subjects/Keywords: Newcastle disease virus; NDV; murine melanoma; murine colon carcinoma; oncolytic virus; immune checkpoint inhibitor; immune checkpoint blockade; cancer immunotherapy; virus purification

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Santry, L. (2018). Production of Preclinical Grade Recombinant Newcastle disease viruses to Enhance Tumor Specific Immune Responses in Syngeneic Mouse Models of Cancer. (Doctoral Dissertation). University of Guelph. Retrieved from https://atrium.lib.uoguelph.ca/xmlui/handle/10214/12313

Chicago Manual of Style (16th Edition):

Santry, Lisa. “Production of Preclinical Grade Recombinant Newcastle disease viruses to Enhance Tumor Specific Immune Responses in Syngeneic Mouse Models of Cancer.” 2018. Doctoral Dissertation, University of Guelph. Accessed January 16, 2021. https://atrium.lib.uoguelph.ca/xmlui/handle/10214/12313.

MLA Handbook (7th Edition):

Santry, Lisa. “Production of Preclinical Grade Recombinant Newcastle disease viruses to Enhance Tumor Specific Immune Responses in Syngeneic Mouse Models of Cancer.” 2018. Web. 16 Jan 2021.

Vancouver:

Santry L. Production of Preclinical Grade Recombinant Newcastle disease viruses to Enhance Tumor Specific Immune Responses in Syngeneic Mouse Models of Cancer. [Internet] [Doctoral dissertation]. University of Guelph; 2018. [cited 2021 Jan 16]. Available from: https://atrium.lib.uoguelph.ca/xmlui/handle/10214/12313.

Council of Science Editors:

Santry L. Production of Preclinical Grade Recombinant Newcastle disease viruses to Enhance Tumor Specific Immune Responses in Syngeneic Mouse Models of Cancer. [Doctoral Dissertation]. University of Guelph; 2018. Available from: https://atrium.lib.uoguelph.ca/xmlui/handle/10214/12313


University of Arizona

3. Almutairi, Abdulaali R. Immune-Related Adverse Events (irAEs) of Immune Checkpoint Inhibitors (ICIs) in Advanced Melanoma Patients .

Degree: 2020, University of Arizona

 Abstract (1): Background: The use of ipilimumab, nivolumab, and pembrolizumab as monotherapies or in combination has transformed the management of advanced melanoma even though these… (more)

Subjects/Keywords: colitis; hypothyroidism; immune checkpoint inhibitors; Immune-Related Adverse Events; melanoma; real-world

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Almutairi, A. R. (2020). Immune-Related Adverse Events (irAEs) of Immune Checkpoint Inhibitors (ICIs) in Advanced Melanoma Patients . (Doctoral Dissertation). University of Arizona. Retrieved from http://hdl.handle.net/10150/641423

Chicago Manual of Style (16th Edition):

Almutairi, Abdulaali R. “Immune-Related Adverse Events (irAEs) of Immune Checkpoint Inhibitors (ICIs) in Advanced Melanoma Patients .” 2020. Doctoral Dissertation, University of Arizona. Accessed January 16, 2021. http://hdl.handle.net/10150/641423.

MLA Handbook (7th Edition):

Almutairi, Abdulaali R. “Immune-Related Adverse Events (irAEs) of Immune Checkpoint Inhibitors (ICIs) in Advanced Melanoma Patients .” 2020. Web. 16 Jan 2021.

Vancouver:

Almutairi AR. Immune-Related Adverse Events (irAEs) of Immune Checkpoint Inhibitors (ICIs) in Advanced Melanoma Patients . [Internet] [Doctoral dissertation]. University of Arizona; 2020. [cited 2021 Jan 16]. Available from: http://hdl.handle.net/10150/641423.

Council of Science Editors:

Almutairi AR. Immune-Related Adverse Events (irAEs) of Immune Checkpoint Inhibitors (ICIs) in Advanced Melanoma Patients . [Doctoral Dissertation]. University of Arizona; 2020. Available from: http://hdl.handle.net/10150/641423

4. Yasuda, Satoshi; Sho, Masayuki; Yamato, Ichiro; Yoshiji, Hitoshi; Wakatsuki, Kohei; Nishiwada, Satoshi; Yagita, Hideo. Simultaneous blockade of programmed death 1 and vascular endothelial growth factor receptor 2 (VEGFR2) induces synergistic anti-tumour effect in vivo : PD-1とVEGFR2の同時阻害による相乗的抗腫瘍効果.

Degree: 博士(医学), 2013, Nara Medical University / 奈良県立医科大学

Recent basic and clinical studies have shown that the programmed death ligand (PD-L)/PD-1 pathway has a significant role in tumour immunity, and its blockade has… (more)

Subjects/Keywords: PD-1; VEGFR2; Immune checkpoint; Antiangiogenesis; Antitumour immunity

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Yasuda, Satoshi; Sho, Masayuki; Yamato, Ichiro; Yoshiji, Hitoshi; Wakatsuki, Kohei; Nishiwada, Satoshi; Yagita, H. (2013). Simultaneous blockade of programmed death 1 and vascular endothelial growth factor receptor 2 (VEGFR2) induces synergistic anti-tumour effect in vivo : PD-1とVEGFR2の同時阻害による相乗的抗腫瘍効果. (Thesis). Nara Medical University / 奈良県立医科大学. Retrieved from http://hdl.handle.net/10564/2588

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Yasuda, Satoshi; Sho, Masayuki; Yamato, Ichiro; Yoshiji, Hitoshi; Wakatsuki, Kohei; Nishiwada, Satoshi; Yagita, Hideo. “Simultaneous blockade of programmed death 1 and vascular endothelial growth factor receptor 2 (VEGFR2) induces synergistic anti-tumour effect in vivo : PD-1とVEGFR2の同時阻害による相乗的抗腫瘍効果.” 2013. Thesis, Nara Medical University / 奈良県立医科大学. Accessed January 16, 2021. http://hdl.handle.net/10564/2588.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Yasuda, Satoshi; Sho, Masayuki; Yamato, Ichiro; Yoshiji, Hitoshi; Wakatsuki, Kohei; Nishiwada, Satoshi; Yagita, Hideo. “Simultaneous blockade of programmed death 1 and vascular endothelial growth factor receptor 2 (VEGFR2) induces synergistic anti-tumour effect in vivo : PD-1とVEGFR2の同時阻害による相乗的抗腫瘍効果.” 2013. Web. 16 Jan 2021.

Vancouver:

Yasuda, Satoshi; Sho, Masayuki; Yamato, Ichiro; Yoshiji, Hitoshi; Wakatsuki, Kohei; Nishiwada, Satoshi; Yagita H. Simultaneous blockade of programmed death 1 and vascular endothelial growth factor receptor 2 (VEGFR2) induces synergistic anti-tumour effect in vivo : PD-1とVEGFR2の同時阻害による相乗的抗腫瘍効果. [Internet] [Thesis]. Nara Medical University / 奈良県立医科大学; 2013. [cited 2021 Jan 16]. Available from: http://hdl.handle.net/10564/2588.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Yasuda, Satoshi; Sho, Masayuki; Yamato, Ichiro; Yoshiji, Hitoshi; Wakatsuki, Kohei; Nishiwada, Satoshi; Yagita H. Simultaneous blockade of programmed death 1 and vascular endothelial growth factor receptor 2 (VEGFR2) induces synergistic anti-tumour effect in vivo : PD-1とVEGFR2の同時阻害による相乗的抗腫瘍効果. [Thesis]. Nara Medical University / 奈良県立医科大学; 2013. Available from: http://hdl.handle.net/10564/2588

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


UCLA

5. Palaskas, Nicolaos Jay. A platform for investigating immune checkpoint-mediated changes in metabolism.

Degree: Molec, Cell, & Integ Physiology, 2017, UCLA

 There is a growing interest in metabolomic profiling of immune cells, as there is accumulating evidence that metabolism influences immune cell function and fate decisions.… (more)

Subjects/Keywords: Immunology; immune checkpoint; immunometabolism; mass spectrometry; metabolomics; PD-1; platform

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Palaskas, N. J. (2017). A platform for investigating immune checkpoint-mediated changes in metabolism. (Thesis). UCLA. Retrieved from http://www.escholarship.org/uc/item/25011272

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Palaskas, Nicolaos Jay. “A platform for investigating immune checkpoint-mediated changes in metabolism.” 2017. Thesis, UCLA. Accessed January 16, 2021. http://www.escholarship.org/uc/item/25011272.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Palaskas, Nicolaos Jay. “A platform for investigating immune checkpoint-mediated changes in metabolism.” 2017. Web. 16 Jan 2021.

Vancouver:

Palaskas NJ. A platform for investigating immune checkpoint-mediated changes in metabolism. [Internet] [Thesis]. UCLA; 2017. [cited 2021 Jan 16]. Available from: http://www.escholarship.org/uc/item/25011272.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Palaskas NJ. A platform for investigating immune checkpoint-mediated changes in metabolism. [Thesis]. UCLA; 2017. Available from: http://www.escholarship.org/uc/item/25011272

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Boston University

6. Garcia-Neuer, Marlene. Systematic diagnostic evaluation for immune-related colitis: a single institutional review of advanced melanoma patients treated with ipilimumab.

Degree: MS, Clinical Investigation, 2016, Boston University

 Colitis can be a life-threatening immune-related adverse event (irAE) for patients with metastatic melanoma treated with immune checkpoint blockade, a new anti-cancer immunotherapy. With the… (more)

Subjects/Keywords: Medicine; Colonoscopy; CT; Melanoma; Checkpoint blockade; Immune therapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Garcia-Neuer, M. (2016). Systematic diagnostic evaluation for immune-related colitis: a single institutional review of advanced melanoma patients treated with ipilimumab. (Masters Thesis). Boston University. Retrieved from http://hdl.handle.net/2144/17019

Chicago Manual of Style (16th Edition):

Garcia-Neuer, Marlene. “Systematic diagnostic evaluation for immune-related colitis: a single institutional review of advanced melanoma patients treated with ipilimumab.” 2016. Masters Thesis, Boston University. Accessed January 16, 2021. http://hdl.handle.net/2144/17019.

MLA Handbook (7th Edition):

Garcia-Neuer, Marlene. “Systematic diagnostic evaluation for immune-related colitis: a single institutional review of advanced melanoma patients treated with ipilimumab.” 2016. Web. 16 Jan 2021.

Vancouver:

Garcia-Neuer M. Systematic diagnostic evaluation for immune-related colitis: a single institutional review of advanced melanoma patients treated with ipilimumab. [Internet] [Masters thesis]. Boston University; 2016. [cited 2021 Jan 16]. Available from: http://hdl.handle.net/2144/17019.

Council of Science Editors:

Garcia-Neuer M. Systematic diagnostic evaluation for immune-related colitis: a single institutional review of advanced melanoma patients treated with ipilimumab. [Masters Thesis]. Boston University; 2016. Available from: http://hdl.handle.net/2144/17019


University of Cincinnati

7. Furnish, Robin. Evaluating Immune Modulatory Therapeutic Strategies for Diffuse Intrinsic Pontine Glioma.

Degree: MS, Pharmacy: Pharmaceutical Sciences, 2020, University of Cincinnati

 Diffuse intrinsic pontine glioma (DIPG) is a rare and lethal pediatric brain tumor arising in?the?midline structures of the brain, namely the pons and thalamus. Surgery… (more)

Subjects/Keywords: Pharmaceuticals; DIPG; CDK4 6; Immune Checkpoint Inhibitor; CDK 4 6 inhibitor

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Furnish, R. (2020). Evaluating Immune Modulatory Therapeutic Strategies for Diffuse Intrinsic Pontine Glioma. (Masters Thesis). University of Cincinnati. Retrieved from http://rave.ohiolink.edu/etdc/view?acc_num=ucin1595849080346532

Chicago Manual of Style (16th Edition):

Furnish, Robin. “Evaluating Immune Modulatory Therapeutic Strategies for Diffuse Intrinsic Pontine Glioma.” 2020. Masters Thesis, University of Cincinnati. Accessed January 16, 2021. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1595849080346532.

MLA Handbook (7th Edition):

Furnish, Robin. “Evaluating Immune Modulatory Therapeutic Strategies for Diffuse Intrinsic Pontine Glioma.” 2020. Web. 16 Jan 2021.

Vancouver:

Furnish R. Evaluating Immune Modulatory Therapeutic Strategies for Diffuse Intrinsic Pontine Glioma. [Internet] [Masters thesis]. University of Cincinnati; 2020. [cited 2021 Jan 16]. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=ucin1595849080346532.

Council of Science Editors:

Furnish R. Evaluating Immune Modulatory Therapeutic Strategies for Diffuse Intrinsic Pontine Glioma. [Masters Thesis]. University of Cincinnati; 2020. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=ucin1595849080346532


Duke University

8. Woroniecka, Karolina. T Cell Exhaustion in Glioblastoma .

Degree: 2020, Duke University

  Glioblastoma (GBM) is the most common primary malignant brain tumor. Despite standard of care treatment GBM remains universally lethal, demonstrating a significant need for… (more)

Subjects/Keywords: Oncology; Immunology; Neurosciences; Glioblastoma; Immune Checkpoint Blockade; T Cell Exhaustion

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Woroniecka, K. (2020). T Cell Exhaustion in Glioblastoma . (Thesis). Duke University. Retrieved from http://hdl.handle.net/10161/20843

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Woroniecka, Karolina. “T Cell Exhaustion in Glioblastoma .” 2020. Thesis, Duke University. Accessed January 16, 2021. http://hdl.handle.net/10161/20843.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Woroniecka, Karolina. “T Cell Exhaustion in Glioblastoma .” 2020. Web. 16 Jan 2021.

Vancouver:

Woroniecka K. T Cell Exhaustion in Glioblastoma . [Internet] [Thesis]. Duke University; 2020. [cited 2021 Jan 16]. Available from: http://hdl.handle.net/10161/20843.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Woroniecka K. T Cell Exhaustion in Glioblastoma . [Thesis]. Duke University; 2020. Available from: http://hdl.handle.net/10161/20843

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Texas Medical Center

9. Jiao, Shiping. PARP inhibitor upregulates PD-L1 expression and enhances cancer-associated immunosuppression.

Degree: MS, 2017, Texas Medical Center

  With recent approvals for therapeutic antibodies that block CTLA4, PD-1 and PD-L1, immune checkpoints have emerged as new targets in cancer therapy. In addition,… (more)

Subjects/Keywords: Cancer Immunotherapy; immune checkpoint; PARP inhibitor; Combination therapy; Cancer Biology; Medical Immunology; Neoplasms; Oncology

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Jiao, S. (2017). PARP inhibitor upregulates PD-L1 expression and enhances cancer-associated immunosuppression. (Thesis). Texas Medical Center. Retrieved from https://digitalcommons.library.tmc.edu/utgsbs_dissertations/739

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Jiao, Shiping. “PARP inhibitor upregulates PD-L1 expression and enhances cancer-associated immunosuppression.” 2017. Thesis, Texas Medical Center. Accessed January 16, 2021. https://digitalcommons.library.tmc.edu/utgsbs_dissertations/739.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Jiao, Shiping. “PARP inhibitor upregulates PD-L1 expression and enhances cancer-associated immunosuppression.” 2017. Web. 16 Jan 2021.

Vancouver:

Jiao S. PARP inhibitor upregulates PD-L1 expression and enhances cancer-associated immunosuppression. [Internet] [Thesis]. Texas Medical Center; 2017. [cited 2021 Jan 16]. Available from: https://digitalcommons.library.tmc.edu/utgsbs_dissertations/739.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Jiao S. PARP inhibitor upregulates PD-L1 expression and enhances cancer-associated immunosuppression. [Thesis]. Texas Medical Center; 2017. Available from: https://digitalcommons.library.tmc.edu/utgsbs_dissertations/739

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Western Ontario

10. El-Hajjar, Mikal. Inducing DNA-Mismatch Repair Deficiency In Tumours: A Strategy To Enhance Anti-Tumour Immunity.

Degree: 2020, University of Western Ontario

 Immunotherapy has improved patient outcomes in advanced or metastatic settings across a number of cancers. Patients with tumours deficient in the DNA mismatch repair (DNA-MMR)… (more)

Subjects/Keywords: Cancer; DNA-MMR Repair; Immunotherapy; Immune checkpoint inhibitors; MLH1; T-cells; Immunity

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

El-Hajjar, M. (2020). Inducing DNA-Mismatch Repair Deficiency In Tumours: A Strategy To Enhance Anti-Tumour Immunity. (Thesis). University of Western Ontario. Retrieved from https://ir.lib.uwo.ca/etd/7432

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

El-Hajjar, Mikal. “Inducing DNA-Mismatch Repair Deficiency In Tumours: A Strategy To Enhance Anti-Tumour Immunity.” 2020. Thesis, University of Western Ontario. Accessed January 16, 2021. https://ir.lib.uwo.ca/etd/7432.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

El-Hajjar, Mikal. “Inducing DNA-Mismatch Repair Deficiency In Tumours: A Strategy To Enhance Anti-Tumour Immunity.” 2020. Web. 16 Jan 2021.

Vancouver:

El-Hajjar M. Inducing DNA-Mismatch Repair Deficiency In Tumours: A Strategy To Enhance Anti-Tumour Immunity. [Internet] [Thesis]. University of Western Ontario; 2020. [cited 2021 Jan 16]. Available from: https://ir.lib.uwo.ca/etd/7432.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

El-Hajjar M. Inducing DNA-Mismatch Repair Deficiency In Tumours: A Strategy To Enhance Anti-Tumour Immunity. [Thesis]. University of Western Ontario; 2020. Available from: https://ir.lib.uwo.ca/etd/7432

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of South Florida

11. Sodre De Castro Laino, Andressa. Targeting Histone Deacetylases in Melanoma and T-cells to Improve Cancer Immunotherapy.

Degree: 2016, University of South Florida

 Histone deacetylases (HDACs) are key mediators of gene expression and, thus, major regulators of cell function. As such, HDACs play a role in orchestrating tumor… (more)

Subjects/Keywords: HDACs; HDAC Inhibitors; Lymphocytes; Immune Checkpoint Blockade; Immunology and Infectious Disease; Oncology

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Sodre De Castro Laino, A. (2016). Targeting Histone Deacetylases in Melanoma and T-cells to Improve Cancer Immunotherapy. (Thesis). University of South Florida. Retrieved from https://scholarcommons.usf.edu/etd/6144

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Sodre De Castro Laino, Andressa. “Targeting Histone Deacetylases in Melanoma and T-cells to Improve Cancer Immunotherapy.” 2016. Thesis, University of South Florida. Accessed January 16, 2021. https://scholarcommons.usf.edu/etd/6144.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Sodre De Castro Laino, Andressa. “Targeting Histone Deacetylases in Melanoma and T-cells to Improve Cancer Immunotherapy.” 2016. Web. 16 Jan 2021.

Vancouver:

Sodre De Castro Laino A. Targeting Histone Deacetylases in Melanoma and T-cells to Improve Cancer Immunotherapy. [Internet] [Thesis]. University of South Florida; 2016. [cited 2021 Jan 16]. Available from: https://scholarcommons.usf.edu/etd/6144.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Sodre De Castro Laino A. Targeting Histone Deacetylases in Melanoma and T-cells to Improve Cancer Immunotherapy. [Thesis]. University of South Florida; 2016. Available from: https://scholarcommons.usf.edu/etd/6144

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Helsinki

12. Lee, Moon Hee. Characterizing the Immune Phenotype of Tumor Infiltrating Lymphocytes in Renal Cell Carcinoma.

Degree: Medicinska fakulteten, 2017, University of Helsinki

 Cancer immunotherapy has advanced with the introduction of anti-PD-1 therapy. Anti-PD-1 therapy blocks the inhibitory immune checkpoint receptor PD-1, and allows T cells to regain… (more)

Subjects/Keywords: RCC; TILs; renal cell carcinoma; NK cell; immune checkpoint; tumor infiltrating lymphocytes; Cancer immunology

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Lee, M. H. (2017). Characterizing the Immune Phenotype of Tumor Infiltrating Lymphocytes in Renal Cell Carcinoma. (Masters Thesis). University of Helsinki. Retrieved from http://hdl.handle.net/10138/191279

Chicago Manual of Style (16th Edition):

Lee, Moon Hee. “Characterizing the Immune Phenotype of Tumor Infiltrating Lymphocytes in Renal Cell Carcinoma.” 2017. Masters Thesis, University of Helsinki. Accessed January 16, 2021. http://hdl.handle.net/10138/191279.

MLA Handbook (7th Edition):

Lee, Moon Hee. “Characterizing the Immune Phenotype of Tumor Infiltrating Lymphocytes in Renal Cell Carcinoma.” 2017. Web. 16 Jan 2021.

Vancouver:

Lee MH. Characterizing the Immune Phenotype of Tumor Infiltrating Lymphocytes in Renal Cell Carcinoma. [Internet] [Masters thesis]. University of Helsinki; 2017. [cited 2021 Jan 16]. Available from: http://hdl.handle.net/10138/191279.

Council of Science Editors:

Lee MH. Characterizing the Immune Phenotype of Tumor Infiltrating Lymphocytes in Renal Cell Carcinoma. [Masters Thesis]. University of Helsinki; 2017. Available from: http://hdl.handle.net/10138/191279


Freie Universität Berlin

13. Strauch, Nicole. Evaluation of Psychosocial Factors and Patient Competence of the Management of Side Effects of Cancer Patients Undergoing Immune-Checkpoint-Inhibitor-Therapy.

Degree: 2020, Freie Universität Berlin

 Introduction Immune checkpoint inhibitors (ICI) have led to significant change of cancer therapy but are associated with immunrelated adverse events which need regular assessment and… (more)

Subjects/Keywords: Immune-Checkpoint-Inhibitor-Therapy; Cancer; Psychooncology; irAEs; Psychosocial Factors; Patient Competence; ddc:610

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Strauch, N. (2020). Evaluation of Psychosocial Factors and Patient Competence of the Management of Side Effects of Cancer Patients Undergoing Immune-Checkpoint-Inhibitor-Therapy. (Thesis). Freie Universität Berlin. Retrieved from http://dx.doi.org/10.17169/refubium-27286

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Strauch, Nicole. “Evaluation of Psychosocial Factors and Patient Competence of the Management of Side Effects of Cancer Patients Undergoing Immune-Checkpoint-Inhibitor-Therapy.” 2020. Thesis, Freie Universität Berlin. Accessed January 16, 2021. http://dx.doi.org/10.17169/refubium-27286.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Strauch, Nicole. “Evaluation of Psychosocial Factors and Patient Competence of the Management of Side Effects of Cancer Patients Undergoing Immune-Checkpoint-Inhibitor-Therapy.” 2020. Web. 16 Jan 2021.

Vancouver:

Strauch N. Evaluation of Psychosocial Factors and Patient Competence of the Management of Side Effects of Cancer Patients Undergoing Immune-Checkpoint-Inhibitor-Therapy. [Internet] [Thesis]. Freie Universität Berlin; 2020. [cited 2021 Jan 16]. Available from: http://dx.doi.org/10.17169/refubium-27286.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Strauch N. Evaluation of Psychosocial Factors and Patient Competence of the Management of Side Effects of Cancer Patients Undergoing Immune-Checkpoint-Inhibitor-Therapy. [Thesis]. Freie Universität Berlin; 2020. Available from: http://dx.doi.org/10.17169/refubium-27286

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Texas Medical Center

14. McGuire, Michael. INVESTIGATING THE IMPACT OF INTRAGENIC DNA METHYLATION ON GENE EXPRESSION, AND THE CLINICAL IMPLICATIONS ON TUMOR CELLS AND ASSOCIATED STROMA.

Degree: PhD, 2018, Texas Medical Center

  Investigations into the function of non-promoter DNA methylation have yielded new insights into epigenetic regulation of gene expression. Previous studies have highlighted the importance… (more)

Subjects/Keywords: 3'UTR; DNA methylation; T cells; Immune checkpoint; Bioinformatics; Medicine and Health Sciences; Molecular Biology; Molecular Genetics

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

McGuire, M. (2018). INVESTIGATING THE IMPACT OF INTRAGENIC DNA METHYLATION ON GENE EXPRESSION, AND THE CLINICAL IMPLICATIONS ON TUMOR CELLS AND ASSOCIATED STROMA. (Doctoral Dissertation). Texas Medical Center. Retrieved from https://digitalcommons.library.tmc.edu/utgsbs_dissertations/852

Chicago Manual of Style (16th Edition):

McGuire, Michael. “INVESTIGATING THE IMPACT OF INTRAGENIC DNA METHYLATION ON GENE EXPRESSION, AND THE CLINICAL IMPLICATIONS ON TUMOR CELLS AND ASSOCIATED STROMA.” 2018. Doctoral Dissertation, Texas Medical Center. Accessed January 16, 2021. https://digitalcommons.library.tmc.edu/utgsbs_dissertations/852.

MLA Handbook (7th Edition):

McGuire, Michael. “INVESTIGATING THE IMPACT OF INTRAGENIC DNA METHYLATION ON GENE EXPRESSION, AND THE CLINICAL IMPLICATIONS ON TUMOR CELLS AND ASSOCIATED STROMA.” 2018. Web. 16 Jan 2021.

Vancouver:

McGuire M. INVESTIGATING THE IMPACT OF INTRAGENIC DNA METHYLATION ON GENE EXPRESSION, AND THE CLINICAL IMPLICATIONS ON TUMOR CELLS AND ASSOCIATED STROMA. [Internet] [Doctoral dissertation]. Texas Medical Center; 2018. [cited 2021 Jan 16]. Available from: https://digitalcommons.library.tmc.edu/utgsbs_dissertations/852.

Council of Science Editors:

McGuire M. INVESTIGATING THE IMPACT OF INTRAGENIC DNA METHYLATION ON GENE EXPRESSION, AND THE CLINICAL IMPLICATIONS ON TUMOR CELLS AND ASSOCIATED STROMA. [Doctoral Dissertation]. Texas Medical Center; 2018. Available from: https://digitalcommons.library.tmc.edu/utgsbs_dissertations/852

15. D'Almeida, Sénan. Rôle de l’éctonucléotidase CD39 dans l’acquisition d’un phénotype immunorégulateur par les macrophages associés aux tumeurs : The ectonucleotidase CD39 in the acquisition of an immunosuppressive phenotype by tumor-associated macrophages.

Degree: Docteur es, Aspects moléculaires et cellulaires de la biologie, 2015, Angers

Les macrophages associés aux tumeurs (TAM) sont des cellules immunorégulatrices qui s’accumulent massivement dans le microenvironnement (ME) tumoral. Chez les patients atteints de cancer de… (more)

Subjects/Keywords: NTPDase1 CD39; Immunorégulation; Points de contrôles immunologiques (PD-L1); NTPDase1 CD39; Immunoregulation; Immune checkpoint (PD-L1); 610

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

D'Almeida, S. (2015). Rôle de l’éctonucléotidase CD39 dans l’acquisition d’un phénotype immunorégulateur par les macrophages associés aux tumeurs : The ectonucleotidase CD39 in the acquisition of an immunosuppressive phenotype by tumor-associated macrophages. (Doctoral Dissertation). Angers. Retrieved from http://www.theses.fr/2015ANGE0006

Chicago Manual of Style (16th Edition):

D'Almeida, Sénan. “Rôle de l’éctonucléotidase CD39 dans l’acquisition d’un phénotype immunorégulateur par les macrophages associés aux tumeurs : The ectonucleotidase CD39 in the acquisition of an immunosuppressive phenotype by tumor-associated macrophages.” 2015. Doctoral Dissertation, Angers. Accessed January 16, 2021. http://www.theses.fr/2015ANGE0006.

MLA Handbook (7th Edition):

D'Almeida, Sénan. “Rôle de l’éctonucléotidase CD39 dans l’acquisition d’un phénotype immunorégulateur par les macrophages associés aux tumeurs : The ectonucleotidase CD39 in the acquisition of an immunosuppressive phenotype by tumor-associated macrophages.” 2015. Web. 16 Jan 2021.

Vancouver:

D'Almeida S. Rôle de l’éctonucléotidase CD39 dans l’acquisition d’un phénotype immunorégulateur par les macrophages associés aux tumeurs : The ectonucleotidase CD39 in the acquisition of an immunosuppressive phenotype by tumor-associated macrophages. [Internet] [Doctoral dissertation]. Angers; 2015. [cited 2021 Jan 16]. Available from: http://www.theses.fr/2015ANGE0006.

Council of Science Editors:

D'Almeida S. Rôle de l’éctonucléotidase CD39 dans l’acquisition d’un phénotype immunorégulateur par les macrophages associés aux tumeurs : The ectonucleotidase CD39 in the acquisition of an immunosuppressive phenotype by tumor-associated macrophages. [Doctoral Dissertation]. Angers; 2015. Available from: http://www.theses.fr/2015ANGE0006

16. Shekarian, Tala. Immunostimulatory and Oncolytic Properties of Rotavirus Can Overcome Resistance to Immune Checkpoint Blockade Therapy : Voie de signalisation de TLR4 et Rig I dans le neuroblastome : rôle biologique, valeur pronostique et utilisation dans les thérapeutique ciblées.

Degree: Docteur es, Immuno-oncologie, 2017, Lyon

L'apport des anticorps immunomodulateurs ciblant PD-1, PD-L1 et CTLA-4 ont récemment révolutionné la prise en charge thérapeutique du cancer. Cependant, seule une minorité de patients… (more)

Subjects/Keywords: Virus oncolytique; Anticorps immunomodulateur; Neuroblastome; Agonistes de PRRs; Oncolytic virus; Immune checkpoint blockade antibodies; Neuroblastoma; PRRs Agonits; 616.99

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Shekarian, T. (2017). Immunostimulatory and Oncolytic Properties of Rotavirus Can Overcome Resistance to Immune Checkpoint Blockade Therapy : Voie de signalisation de TLR4 et Rig I dans le neuroblastome : rôle biologique, valeur pronostique et utilisation dans les thérapeutique ciblées. (Doctoral Dissertation). Lyon. Retrieved from http://www.theses.fr/2017LYSE1048

Chicago Manual of Style (16th Edition):

Shekarian, Tala. “Immunostimulatory and Oncolytic Properties of Rotavirus Can Overcome Resistance to Immune Checkpoint Blockade Therapy : Voie de signalisation de TLR4 et Rig I dans le neuroblastome : rôle biologique, valeur pronostique et utilisation dans les thérapeutique ciblées.” 2017. Doctoral Dissertation, Lyon. Accessed January 16, 2021. http://www.theses.fr/2017LYSE1048.

MLA Handbook (7th Edition):

Shekarian, Tala. “Immunostimulatory and Oncolytic Properties of Rotavirus Can Overcome Resistance to Immune Checkpoint Blockade Therapy : Voie de signalisation de TLR4 et Rig I dans le neuroblastome : rôle biologique, valeur pronostique et utilisation dans les thérapeutique ciblées.” 2017. Web. 16 Jan 2021.

Vancouver:

Shekarian T. Immunostimulatory and Oncolytic Properties of Rotavirus Can Overcome Resistance to Immune Checkpoint Blockade Therapy : Voie de signalisation de TLR4 et Rig I dans le neuroblastome : rôle biologique, valeur pronostique et utilisation dans les thérapeutique ciblées. [Internet] [Doctoral dissertation]. Lyon; 2017. [cited 2021 Jan 16]. Available from: http://www.theses.fr/2017LYSE1048.

Council of Science Editors:

Shekarian T. Immunostimulatory and Oncolytic Properties of Rotavirus Can Overcome Resistance to Immune Checkpoint Blockade Therapy : Voie de signalisation de TLR4 et Rig I dans le neuroblastome : rôle biologique, valeur pronostique et utilisation dans les thérapeutique ciblées. [Doctoral Dissertation]. Lyon; 2017. Available from: http://www.theses.fr/2017LYSE1048


University of Gothenburg / Göteborgs Universitet

17. Ahlmanner, Filip. Regulatory T cells and mucosal-associated invariant T cells in colon adenocarcinomas; Phenotype and function.

Degree: 2019, University of Gothenburg / Göteborgs Universitet

 In many solid cancers, and also in colon adenocarcinomas, an increased accumulation of lymphocytes is beneficial for the patient. However, tumor-infiltrating immune cells may be… (more)

Subjects/Keywords: colon cancer; regulatory T cells; CD39; adenosine; immune checkpoint molecules; immunosuppression; MAIT cells; cytokines; cancer-specific survival

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Ahlmanner, F. (2019). Regulatory T cells and mucosal-associated invariant T cells in colon adenocarcinomas; Phenotype and function. (Thesis). University of Gothenburg / Göteborgs Universitet. Retrieved from http://hdl.handle.net/2077/58240

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Ahlmanner, Filip. “Regulatory T cells and mucosal-associated invariant T cells in colon adenocarcinomas; Phenotype and function.” 2019. Thesis, University of Gothenburg / Göteborgs Universitet. Accessed January 16, 2021. http://hdl.handle.net/2077/58240.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Ahlmanner, Filip. “Regulatory T cells and mucosal-associated invariant T cells in colon adenocarcinomas; Phenotype and function.” 2019. Web. 16 Jan 2021.

Vancouver:

Ahlmanner F. Regulatory T cells and mucosal-associated invariant T cells in colon adenocarcinomas; Phenotype and function. [Internet] [Thesis]. University of Gothenburg / Göteborgs Universitet; 2019. [cited 2021 Jan 16]. Available from: http://hdl.handle.net/2077/58240.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Ahlmanner F. Regulatory T cells and mucosal-associated invariant T cells in colon adenocarcinomas; Phenotype and function. [Thesis]. University of Gothenburg / Göteborgs Universitet; 2019. Available from: http://hdl.handle.net/2077/58240

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Victoria

18. Hanley, Ronan. Inhibitors of the PD1/PD-L1 interaction: missteps, mechanisms and mysteries.

Degree: Department of Chemistry, 2018, University of Victoria

 The interactions of tumours with normal host tissue are key determinants of cancer growth and progression. The ability or inability of the patient’s immune system… (more)

Subjects/Keywords: chemical biology; immunology; oncology; immune checkpoint; programmed death 1; PD1; PDL1; programmed death ligand 1; assay interference

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Hanley, R. (2018). Inhibitors of the PD1/PD-L1 interaction: missteps, mechanisms and mysteries. (Thesis). University of Victoria. Retrieved from https://dspace.library.uvic.ca//handle/1828/9136

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Hanley, Ronan. “Inhibitors of the PD1/PD-L1 interaction: missteps, mechanisms and mysteries.” 2018. Thesis, University of Victoria. Accessed January 16, 2021. https://dspace.library.uvic.ca//handle/1828/9136.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Hanley, Ronan. “Inhibitors of the PD1/PD-L1 interaction: missteps, mechanisms and mysteries.” 2018. Web. 16 Jan 2021.

Vancouver:

Hanley R. Inhibitors of the PD1/PD-L1 interaction: missteps, mechanisms and mysteries. [Internet] [Thesis]. University of Victoria; 2018. [cited 2021 Jan 16]. Available from: https://dspace.library.uvic.ca//handle/1828/9136.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Hanley R. Inhibitors of the PD1/PD-L1 interaction: missteps, mechanisms and mysteries. [Thesis]. University of Victoria; 2018. Available from: https://dspace.library.uvic.ca//handle/1828/9136

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

19. TAY CHIN KANG JOHAN. IMMUNOTHERAPY AGAINST ADVANCED CANCERS – CHIMERIC ANTIGEN RECEPTOR-BASED APPROACH AND IMMUNE CHECKPOINT REGULATION.

Degree: 2019, National University of Singapore

Subjects/Keywords: CAR; CSR; NGK2D; immune checkpoint; cancer immunotherapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

JOHAN, T. C. K. (2019). IMMUNOTHERAPY AGAINST ADVANCED CANCERS – CHIMERIC ANTIGEN RECEPTOR-BASED APPROACH AND IMMUNE CHECKPOINT REGULATION. (Thesis). National University of Singapore. Retrieved from https://scholarbank.nus.edu.sg/handle/10635/154169

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

JOHAN, TAY CHIN KANG. “IMMUNOTHERAPY AGAINST ADVANCED CANCERS – CHIMERIC ANTIGEN RECEPTOR-BASED APPROACH AND IMMUNE CHECKPOINT REGULATION.” 2019. Thesis, National University of Singapore. Accessed January 16, 2021. https://scholarbank.nus.edu.sg/handle/10635/154169.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

JOHAN, TAY CHIN KANG. “IMMUNOTHERAPY AGAINST ADVANCED CANCERS – CHIMERIC ANTIGEN RECEPTOR-BASED APPROACH AND IMMUNE CHECKPOINT REGULATION.” 2019. Web. 16 Jan 2021.

Vancouver:

JOHAN TCK. IMMUNOTHERAPY AGAINST ADVANCED CANCERS – CHIMERIC ANTIGEN RECEPTOR-BASED APPROACH AND IMMUNE CHECKPOINT REGULATION. [Internet] [Thesis]. National University of Singapore; 2019. [cited 2021 Jan 16]. Available from: https://scholarbank.nus.edu.sg/handle/10635/154169.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

JOHAN TCK. IMMUNOTHERAPY AGAINST ADVANCED CANCERS – CHIMERIC ANTIGEN RECEPTOR-BASED APPROACH AND IMMUNE CHECKPOINT REGULATION. [Thesis]. National University of Singapore; 2019. Available from: https://scholarbank.nus.edu.sg/handle/10635/154169

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Toronto

20. Reguera Núñez, Elaine. Biologic and Therapeutic Studies to Improve the Anti-tumor Efficacy of Antiangiogenic Tyrosine Kinase Inhibitors.

Degree: PhD, 2019, University of Toronto

 Antiangiogenic tyrosine kinase inhibitors (TKIs), unlike VEGF pathway-targeting antibodies, have failed to show meaningful antitumor efficacy in most solid cancer types, even when combined with… (more)

Subjects/Keywords: antiangiogenic drugs; bone marrow-derived cells; immune checkpoint inhibitor; metastasis; preclinical models; tyrosine kinase inhibitors; 0992

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Reguera Núñez, E. (2019). Biologic and Therapeutic Studies to Improve the Anti-tumor Efficacy of Antiangiogenic Tyrosine Kinase Inhibitors. (Doctoral Dissertation). University of Toronto. Retrieved from http://hdl.handle.net/1807/97030

Chicago Manual of Style (16th Edition):

Reguera Núñez, Elaine. “Biologic and Therapeutic Studies to Improve the Anti-tumor Efficacy of Antiangiogenic Tyrosine Kinase Inhibitors.” 2019. Doctoral Dissertation, University of Toronto. Accessed January 16, 2021. http://hdl.handle.net/1807/97030.

MLA Handbook (7th Edition):

Reguera Núñez, Elaine. “Biologic and Therapeutic Studies to Improve the Anti-tumor Efficacy of Antiangiogenic Tyrosine Kinase Inhibitors.” 2019. Web. 16 Jan 2021.

Vancouver:

Reguera Núñez E. Biologic and Therapeutic Studies to Improve the Anti-tumor Efficacy of Antiangiogenic Tyrosine Kinase Inhibitors. [Internet] [Doctoral dissertation]. University of Toronto; 2019. [cited 2021 Jan 16]. Available from: http://hdl.handle.net/1807/97030.

Council of Science Editors:

Reguera Núñez E. Biologic and Therapeutic Studies to Improve the Anti-tumor Efficacy of Antiangiogenic Tyrosine Kinase Inhibitors. [Doctoral Dissertation]. University of Toronto; 2019. Available from: http://hdl.handle.net/1807/97030


University of South Florida

21. Xie, Mengyu. A Novel Cytokine Response Modulatory Function of MEK Inhibitors Mediates Therapeutic Efficacy.

Degree: 2019, University of South Florida

 Despite the recent success of immune-checkpoint blockade therapy for late-stage non-small cell lung cancer (NSCLC), lung cancer is still the leading cause of cancer deaths… (more)

Subjects/Keywords: IFNγ; Immune Checkpoint Blockade; Lung cancer; MEK inhibitors; NF-κB; TNFα; Immunology and Infectious Disease; Molecular Biology

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Xie, M. (2019). A Novel Cytokine Response Modulatory Function of MEK Inhibitors Mediates Therapeutic Efficacy. (Thesis). University of South Florida. Retrieved from https://scholarcommons.usf.edu/etd/8094

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Xie, Mengyu. “A Novel Cytokine Response Modulatory Function of MEK Inhibitors Mediates Therapeutic Efficacy.” 2019. Thesis, University of South Florida. Accessed January 16, 2021. https://scholarcommons.usf.edu/etd/8094.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Xie, Mengyu. “A Novel Cytokine Response Modulatory Function of MEK Inhibitors Mediates Therapeutic Efficacy.” 2019. Web. 16 Jan 2021.

Vancouver:

Xie M. A Novel Cytokine Response Modulatory Function of MEK Inhibitors Mediates Therapeutic Efficacy. [Internet] [Thesis]. University of South Florida; 2019. [cited 2021 Jan 16]. Available from: https://scholarcommons.usf.edu/etd/8094.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Xie M. A Novel Cytokine Response Modulatory Function of MEK Inhibitors Mediates Therapeutic Efficacy. [Thesis]. University of South Florida; 2019. Available from: https://scholarcommons.usf.edu/etd/8094

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Kentucky

22. El-Refai, Sherif M. EXPLORING THE EFFECT OF CHRONIC INFLAMMATION ON RESPONSE TO IMMUNE CHECKPOINT INHIBITORS IN CANCER.

Degree: 2018, University of Kentucky

 Precision medicine has allowed for the development of monoclonal antibodies that unmask the anti-tumor immune response. These agents have provided some patients durable clinical benefit.… (more)

Subjects/Keywords: Immune checkpoint inhibitors; biomarkers of response; health outcomes research; cancer; PD-1/PD-L1; Pharmacy and Pharmaceutical Sciences

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

El-Refai, S. M. (2018). EXPLORING THE EFFECT OF CHRONIC INFLAMMATION ON RESPONSE TO IMMUNE CHECKPOINT INHIBITORS IN CANCER. (Doctoral Dissertation). University of Kentucky. Retrieved from https://uknowledge.uky.edu/pharmacy_etds/82

Chicago Manual of Style (16th Edition):

El-Refai, Sherif M. “EXPLORING THE EFFECT OF CHRONIC INFLAMMATION ON RESPONSE TO IMMUNE CHECKPOINT INHIBITORS IN CANCER.” 2018. Doctoral Dissertation, University of Kentucky. Accessed January 16, 2021. https://uknowledge.uky.edu/pharmacy_etds/82.

MLA Handbook (7th Edition):

El-Refai, Sherif M. “EXPLORING THE EFFECT OF CHRONIC INFLAMMATION ON RESPONSE TO IMMUNE CHECKPOINT INHIBITORS IN CANCER.” 2018. Web. 16 Jan 2021.

Vancouver:

El-Refai SM. EXPLORING THE EFFECT OF CHRONIC INFLAMMATION ON RESPONSE TO IMMUNE CHECKPOINT INHIBITORS IN CANCER. [Internet] [Doctoral dissertation]. University of Kentucky; 2018. [cited 2021 Jan 16]. Available from: https://uknowledge.uky.edu/pharmacy_etds/82.

Council of Science Editors:

El-Refai SM. EXPLORING THE EFFECT OF CHRONIC INFLAMMATION ON RESPONSE TO IMMUNE CHECKPOINT INHIBITORS IN CANCER. [Doctoral Dissertation]. University of Kentucky; 2018. Available from: https://uknowledge.uky.edu/pharmacy_etds/82


Kyoto University

23. Mulati, Kumuluzi. VISTA expressed in tumor cells regulates T cell function .

Degree: 2019, Kyoto University

Subjects/Keywords: VISTA; immune checkpoint; cancer immunotherapy; B7-H5; PD-1

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Mulati, K. (2019). VISTA expressed in tumor cells regulates T cell function . (Thesis). Kyoto University. Retrieved from http://hdl.handle.net/2433/242370

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Mulati, Kumuluzi. “VISTA expressed in tumor cells regulates T cell function .” 2019. Thesis, Kyoto University. Accessed January 16, 2021. http://hdl.handle.net/2433/242370.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Mulati, Kumuluzi. “VISTA expressed in tumor cells regulates T cell function .” 2019. Web. 16 Jan 2021.

Vancouver:

Mulati K. VISTA expressed in tumor cells regulates T cell function . [Internet] [Thesis]. Kyoto University; 2019. [cited 2021 Jan 16]. Available from: http://hdl.handle.net/2433/242370.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Mulati K. VISTA expressed in tumor cells regulates T cell function . [Thesis]. Kyoto University; 2019. Available from: http://hdl.handle.net/2433/242370

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

24. Hartley, Genevieve. PD-L1 expression by tumor macrophages: regulation and signaling.

Degree: PhD, Cell and Molecular Biology, 2018, Colorado State University

To view the abstract, please see the full text of the document. Advisors/Committee Members: Dow, Steven (advisor), Schenkel, Alan (committee member), Gonzalez-Juarrero, Mercedes (committee member), Biller, Barbara (committee member).

Subjects/Keywords: canine; macrophage; cancer; tumor; immune checkpoint

…1 The first immune checkpoint: CTLA-4… …5 Future directions for immune checkpoint blockade… …110 ix CHAPTER 1 Review of the Literature The first immune checkpoint: CTLA-4. Tumor… …conditions, immune checkpoint molecules prevent autoimmunity and protect tissues from damage by… …CD152) was the first immune checkpoint molecule to be clinically targeted with monoclonal… 

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Hartley, G. (2018). PD-L1 expression by tumor macrophages: regulation and signaling. (Doctoral Dissertation). Colorado State University. Retrieved from http://hdl.handle.net/10217/189353

Chicago Manual of Style (16th Edition):

Hartley, Genevieve. “PD-L1 expression by tumor macrophages: regulation and signaling.” 2018. Doctoral Dissertation, Colorado State University. Accessed January 16, 2021. http://hdl.handle.net/10217/189353.

MLA Handbook (7th Edition):

Hartley, Genevieve. “PD-L1 expression by tumor macrophages: regulation and signaling.” 2018. Web. 16 Jan 2021.

Vancouver:

Hartley G. PD-L1 expression by tumor macrophages: regulation and signaling. [Internet] [Doctoral dissertation]. Colorado State University; 2018. [cited 2021 Jan 16]. Available from: http://hdl.handle.net/10217/189353.

Council of Science Editors:

Hartley G. PD-L1 expression by tumor macrophages: regulation and signaling. [Doctoral Dissertation]. Colorado State University; 2018. Available from: http://hdl.handle.net/10217/189353


University of Queensland

25. Addala, Venkateswara. Therapeutic Opportunity in Cancers with Poor Survival.

Degree: Faculty of Medicine, 2020, University of Queensland

 Next generation sequencing has allowed researchers to characterise the somatic landscape of cancer genomes, which has led to the discovery of biomarkers that may be… (more)

Subjects/Keywords: cancer immunotherapy; immune checkpoint blockade; neoantigens; whole genome sequencing; rna sequencing; mesothelioma; mss cold tumours; melanoma; tumour microenvironment; immune cells deconvolution; 0601 Biochemistry and Cell Biology; 0604 Genetics; 1107 Immunology

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Addala, V. (2020). Therapeutic Opportunity in Cancers with Poor Survival. (Thesis). University of Queensland. Retrieved from http://espace.library.uq.edu.au/view/UQ:9

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Addala, Venkateswara. “Therapeutic Opportunity in Cancers with Poor Survival.” 2020. Thesis, University of Queensland. Accessed January 16, 2021. http://espace.library.uq.edu.au/view/UQ:9.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Addala, Venkateswara. “Therapeutic Opportunity in Cancers with Poor Survival.” 2020. Web. 16 Jan 2021.

Vancouver:

Addala V. Therapeutic Opportunity in Cancers with Poor Survival. [Internet] [Thesis]. University of Queensland; 2020. [cited 2021 Jan 16]. Available from: http://espace.library.uq.edu.au/view/UQ:9.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Addala V. Therapeutic Opportunity in Cancers with Poor Survival. [Thesis]. University of Queensland; 2020. Available from: http://espace.library.uq.edu.au/view/UQ:9

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Texas Medical Center

26. Roh, Whijae. INTEGRATIVE CANCER IMMUNOGENOMIC ANALYSIS OF SERIAL MELANOMA BIOPSIES REVEALS CORRELATES OF RESPONSE AND RESISTANCE TO SEQUENTIAL CTLA-4 AND PD-1 BLOCKADE TREATMENT.

Degree: PhD, 2017, Texas Medical Center

  Melanoma is the most malignant form of skin cancer. The five-year survival rate for metastatic melanoma is 19.9%. Although targeted therapy of BRAF and… (more)

Subjects/Keywords: cancer immunology; immunotherapy; immune checkpoint blockade; CTLA-4; PD-1; genomics; melanoma; response; resistance; biomarker; Bioinformatics; Computational Biology; Genomics; Medical Immunology; Medicine and Health Sciences; Skin and Connective Tissue Diseases

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Roh, W. (2017). INTEGRATIVE CANCER IMMUNOGENOMIC ANALYSIS OF SERIAL MELANOMA BIOPSIES REVEALS CORRELATES OF RESPONSE AND RESISTANCE TO SEQUENTIAL CTLA-4 AND PD-1 BLOCKADE TREATMENT. (Doctoral Dissertation). Texas Medical Center. Retrieved from https://digitalcommons.library.tmc.edu/utgsbs_dissertations/813

Chicago Manual of Style (16th Edition):

Roh, Whijae. “INTEGRATIVE CANCER IMMUNOGENOMIC ANALYSIS OF SERIAL MELANOMA BIOPSIES REVEALS CORRELATES OF RESPONSE AND RESISTANCE TO SEQUENTIAL CTLA-4 AND PD-1 BLOCKADE TREATMENT.” 2017. Doctoral Dissertation, Texas Medical Center. Accessed January 16, 2021. https://digitalcommons.library.tmc.edu/utgsbs_dissertations/813.

MLA Handbook (7th Edition):

Roh, Whijae. “INTEGRATIVE CANCER IMMUNOGENOMIC ANALYSIS OF SERIAL MELANOMA BIOPSIES REVEALS CORRELATES OF RESPONSE AND RESISTANCE TO SEQUENTIAL CTLA-4 AND PD-1 BLOCKADE TREATMENT.” 2017. Web. 16 Jan 2021.

Vancouver:

Roh W. INTEGRATIVE CANCER IMMUNOGENOMIC ANALYSIS OF SERIAL MELANOMA BIOPSIES REVEALS CORRELATES OF RESPONSE AND RESISTANCE TO SEQUENTIAL CTLA-4 AND PD-1 BLOCKADE TREATMENT. [Internet] [Doctoral dissertation]. Texas Medical Center; 2017. [cited 2021 Jan 16]. Available from: https://digitalcommons.library.tmc.edu/utgsbs_dissertations/813.

Council of Science Editors:

Roh W. INTEGRATIVE CANCER IMMUNOGENOMIC ANALYSIS OF SERIAL MELANOMA BIOPSIES REVEALS CORRELATES OF RESPONSE AND RESISTANCE TO SEQUENTIAL CTLA-4 AND PD-1 BLOCKADE TREATMENT. [Doctoral Dissertation]. Texas Medical Center; 2017. Available from: https://digitalcommons.library.tmc.edu/utgsbs_dissertations/813


University of Hawaii

27. Clements, Danielle M. REGULATION OF CD8 T-CELL FUNCTION BY MULTIPLE NEGATIVE IMMUNE CHECKPOINT MOLECULES DURING HTLV-1 INFECTION.

Degree: 2020, University of Hawaii

Subjects/Keywords: Translation studies; Immunology; HTLV-1; Immune checkpoint blockade; Immunotherapy; T-cell dysfunction

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Clements, D. M. (2020). REGULATION OF CD8 T-CELL FUNCTION BY MULTIPLE NEGATIVE IMMUNE CHECKPOINT MOLECULES DURING HTLV-1 INFECTION. (Thesis). University of Hawaii. Retrieved from http://hdl.handle.net/10125/68913

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Clements, Danielle M. “REGULATION OF CD8 T-CELL FUNCTION BY MULTIPLE NEGATIVE IMMUNE CHECKPOINT MOLECULES DURING HTLV-1 INFECTION.” 2020. Thesis, University of Hawaii. Accessed January 16, 2021. http://hdl.handle.net/10125/68913.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Clements, Danielle M. “REGULATION OF CD8 T-CELL FUNCTION BY MULTIPLE NEGATIVE IMMUNE CHECKPOINT MOLECULES DURING HTLV-1 INFECTION.” 2020. Web. 16 Jan 2021.

Vancouver:

Clements DM. REGULATION OF CD8 T-CELL FUNCTION BY MULTIPLE NEGATIVE IMMUNE CHECKPOINT MOLECULES DURING HTLV-1 INFECTION. [Internet] [Thesis]. University of Hawaii; 2020. [cited 2021 Jan 16]. Available from: http://hdl.handle.net/10125/68913.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Clements DM. REGULATION OF CD8 T-CELL FUNCTION BY MULTIPLE NEGATIVE IMMUNE CHECKPOINT MOLECULES DURING HTLV-1 INFECTION. [Thesis]. University of Hawaii; 2020. Available from: http://hdl.handle.net/10125/68913

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


George Mason University

28. Dey, Douglass. Investigation of Small Peptide Inhibitors on PD-1 PD-L1 Protein-Protein Interactions .

Degree: George Mason University

 Cancer is a complex disease in which abnormal cells divide uncontrollably and invade body tissues, leading to eventual organ failure and death. These abnormal cells… (more)

Subjects/Keywords: PD-1; PD-L1; small peptide inhibitors; checkpoint inhibition; immune checkpoints; cancer immunotherapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Dey, D. (n.d.). Investigation of Small Peptide Inhibitors on PD-1 PD-L1 Protein-Protein Interactions . (Thesis). George Mason University. Retrieved from http://hdl.handle.net/1920/11121

Note: this citation may be lacking information needed for this citation format:
No year of publication.
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Dey, Douglass. “Investigation of Small Peptide Inhibitors on PD-1 PD-L1 Protein-Protein Interactions .” Thesis, George Mason University. Accessed January 16, 2021. http://hdl.handle.net/1920/11121.

Note: this citation may be lacking information needed for this citation format:
No year of publication.
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Dey, Douglass. “Investigation of Small Peptide Inhibitors on PD-1 PD-L1 Protein-Protein Interactions .” Web. 16 Jan 2021.

Note: this citation may be lacking information needed for this citation format:
No year of publication.

Vancouver:

Dey D. Investigation of Small Peptide Inhibitors on PD-1 PD-L1 Protein-Protein Interactions . [Internet] [Thesis]. George Mason University; [cited 2021 Jan 16]. Available from: http://hdl.handle.net/1920/11121.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
No year of publication.

Council of Science Editors:

Dey D. Investigation of Small Peptide Inhibitors on PD-1 PD-L1 Protein-Protein Interactions . [Thesis]. George Mason University; Available from: http://hdl.handle.net/1920/11121

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
No year of publication.


Arizona State University

29. Nikolopoulou, Elpiniki. Mathematical Modeling of Novel Cancer Immunotherapies.

Degree: Applied Mathematics, 2020, Arizona State University

Subjects/Keywords: Applied mathematics; Avelumab; Identifiability; Immune checkpoint Inhibitors; Immunotherapy; Mathematical Modeling; Oncolytic Virus Therapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Nikolopoulou, E. (2020). Mathematical Modeling of Novel Cancer Immunotherapies. (Doctoral Dissertation). Arizona State University. Retrieved from http://repository.asu.edu/items/62684

Chicago Manual of Style (16th Edition):

Nikolopoulou, Elpiniki. “Mathematical Modeling of Novel Cancer Immunotherapies.” 2020. Doctoral Dissertation, Arizona State University. Accessed January 16, 2021. http://repository.asu.edu/items/62684.

MLA Handbook (7th Edition):

Nikolopoulou, Elpiniki. “Mathematical Modeling of Novel Cancer Immunotherapies.” 2020. Web. 16 Jan 2021.

Vancouver:

Nikolopoulou E. Mathematical Modeling of Novel Cancer Immunotherapies. [Internet] [Doctoral dissertation]. Arizona State University; 2020. [cited 2021 Jan 16]. Available from: http://repository.asu.edu/items/62684.

Council of Science Editors:

Nikolopoulou E. Mathematical Modeling of Novel Cancer Immunotherapies. [Doctoral Dissertation]. Arizona State University; 2020. Available from: http://repository.asu.edu/items/62684

30. Wierz, Marina. Characterization of the Tumor Microenvironment in Chronic Lymphocytic Leukemia by Mass Cytometry : Implications for Immunotherapy : Caractérisation du microenvironnement tumoral dans la leucémie lymphoïde chronique par cytométrie de masse : implications pour l'immunothérapie.

Degree: Docteur es, Aspects moléculaires et cellulaires de la biologie, 2020, université Paris-Saclay

La leucémie lymphoïde chronique (LLC), la leucémie la plus fréquente chez l'adulte, est caractérisée par l'accumulation de lymphocytes B matures dans le sang périphérique et… (more)

Subjects/Keywords: Leucémie lymphoïde chronique; Microenvironment tumoral; Cytométrie de masse; Imunothérapie; Point de contrôle immunitaire; Chronic lymphocytic leukemia; Tumor microenvironment; Mass cytometry; Immunotherapy; Immune checkpoint

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Wierz, M. (2020). Characterization of the Tumor Microenvironment in Chronic Lymphocytic Leukemia by Mass Cytometry : Implications for Immunotherapy : Caractérisation du microenvironnement tumoral dans la leucémie lymphoïde chronique par cytométrie de masse : implications pour l'immunothérapie. (Doctoral Dissertation). université Paris-Saclay. Retrieved from http://www.theses.fr/2020UPASL020

Chicago Manual of Style (16th Edition):

Wierz, Marina. “Characterization of the Tumor Microenvironment in Chronic Lymphocytic Leukemia by Mass Cytometry : Implications for Immunotherapy : Caractérisation du microenvironnement tumoral dans la leucémie lymphoïde chronique par cytométrie de masse : implications pour l'immunothérapie.” 2020. Doctoral Dissertation, université Paris-Saclay. Accessed January 16, 2021. http://www.theses.fr/2020UPASL020.

MLA Handbook (7th Edition):

Wierz, Marina. “Characterization of the Tumor Microenvironment in Chronic Lymphocytic Leukemia by Mass Cytometry : Implications for Immunotherapy : Caractérisation du microenvironnement tumoral dans la leucémie lymphoïde chronique par cytométrie de masse : implications pour l'immunothérapie.” 2020. Web. 16 Jan 2021.

Vancouver:

Wierz M. Characterization of the Tumor Microenvironment in Chronic Lymphocytic Leukemia by Mass Cytometry : Implications for Immunotherapy : Caractérisation du microenvironnement tumoral dans la leucémie lymphoïde chronique par cytométrie de masse : implications pour l'immunothérapie. [Internet] [Doctoral dissertation]. université Paris-Saclay; 2020. [cited 2021 Jan 16]. Available from: http://www.theses.fr/2020UPASL020.

Council of Science Editors:

Wierz M. Characterization of the Tumor Microenvironment in Chronic Lymphocytic Leukemia by Mass Cytometry : Implications for Immunotherapy : Caractérisation du microenvironnement tumoral dans la leucémie lymphoïde chronique par cytométrie de masse : implications pour l'immunothérapie. [Doctoral Dissertation]. université Paris-Saclay; 2020. Available from: http://www.theses.fr/2020UPASL020

[1] [2]

.